vs

Side-by-side financial comparison of BayCom Corp (BCML) and BIOLIFE SOLUTIONS INC (BLFS). Click either name above to swap in a different company.

BayCom Corp is the larger business by last-quarter revenue ($25.9M vs $18.8M, roughly 1.4× BIOLIFE SOLUTIONS INC). BIOLIFE SOLUTIONS INC runs the higher net margin — 58.9% vs 26.5%, a 32.4% gap on every dollar of revenue. On growth, BIOLIFE SOLUTIONS INC posted the faster year-over-year revenue change (24.3% vs 9.4%). Over the past eight quarters, BayCom Corp's revenue compounded faster (2.9% CAGR vs 1.0%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

BCML vs BLFS — Head-to-Head

Bigger by revenue
BCML
BCML
1.4× larger
BCML
$25.9M
$18.8M
BLFS
Growing faster (revenue YoY)
BLFS
BLFS
+14.9% gap
BLFS
24.3%
9.4%
BCML
Higher net margin
BLFS
BLFS
32.4% more per $
BLFS
58.9%
26.5%
BCML
Faster 2-yr revenue CAGR
BCML
BCML
Annualised
BCML
2.9%
1.0%
BLFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
BLFS
BLFS
Revenue
$25.9M
$18.8M
Net Profit
$6.9M
$11.1M
Gross Margin
Operating Margin
36.6%
7.2%
Net Margin
26.5%
58.9%
Revenue YoY
9.4%
24.3%
Net Profit YoY
12.1%
-11.1%
EPS (diluted)
$0.63
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
BLFS
BLFS
Q4 25
$25.9M
$18.8M
Q3 25
$25.7M
$28.1M
Q2 25
$24.7M
$25.4M
Q1 25
$24.3M
$23.9M
Q4 24
$23.7M
$15.1M
Q3 24
$25.6M
$21.4M
Q2 24
$23.8M
$19.7M
Q1 24
$24.5M
$18.4M
Net Profit
BCML
BCML
BLFS
BLFS
Q4 25
$6.9M
$11.1M
Q3 25
$5.0M
$621.0K
Q2 25
$6.4M
$-15.8M
Q1 25
$5.7M
$-448.0K
Q4 24
$6.1M
$12.5M
Q3 24
$6.0M
$-1.7M
Q2 24
$5.6M
$-20.7M
Q1 24
$5.9M
$-10.2M
Operating Margin
BCML
BCML
BLFS
BLFS
Q4 25
36.6%
7.2%
Q3 25
26.3%
-0.3%
Q2 25
35.3%
-65.5%
Q1 25
31.6%
-5.1%
Q4 24
34.2%
3.6%
Q3 24
32.4%
-2.0%
Q2 24
31.9%
-6.6%
Q1 24
33.3%
-17.9%
Net Margin
BCML
BCML
BLFS
BLFS
Q4 25
26.5%
58.9%
Q3 25
19.5%
2.2%
Q2 25
25.8%
-62.3%
Q1 25
23.4%
-1.9%
Q4 24
25.9%
82.5%
Q3 24
23.5%
-8.0%
Q2 24
23.6%
-105.1%
Q1 24
24.0%
-55.4%
EPS (diluted)
BCML
BCML
BLFS
BLFS
Q4 25
$0.63
$0.23
Q3 25
$0.46
$0.01
Q2 25
$0.58
$-0.33
Q1 25
$0.51
$-0.01
Q4 24
$0.55
$0.27
Q3 24
$0.54
$-0.04
Q2 24
$0.50
$-0.45
Q1 24
$0.51
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
BLFS
BLFS
Cash + ST InvestmentsLiquidity on hand
$33.0M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$338.6M
$371.9M
Total Assets
$2.6B
$405.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
BLFS
BLFS
Q4 25
$33.0M
Q3 25
$29.5M
Q2 25
$31.9M
Q1 25
$66.9M
Q4 24
$91.5M
Q3 24
$24.0M
Q2 24
$22.0M
Q1 24
$29.7M
Total Debt
BCML
BCML
BLFS
BLFS
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Q1 24
$24.3M
Stockholders' Equity
BCML
BCML
BLFS
BLFS
Q4 25
$338.6M
$371.9M
Q3 25
$334.3M
$353.7M
Q2 25
$330.6M
$347.2M
Q1 25
$329.3M
$352.6M
Q4 24
$324.4M
$348.9M
Q3 24
$321.7M
$325.5M
Q2 24
$315.3M
$321.4M
Q1 24
$314.2M
$333.4M
Total Assets
BCML
BCML
BLFS
BLFS
Q4 25
$2.6B
$405.9M
Q3 25
$2.6B
$392.1M
Q2 25
$2.6B
$387.2M
Q1 25
$2.6B
$395.1M
Q4 24
$2.7B
$399.5M
Q3 24
$2.6B
$381.7M
Q2 24
$2.6B
$375.0M
Q1 24
$2.6B
$401.6M
Debt / Equity
BCML
BCML
BLFS
BLFS
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
BLFS
BLFS
Operating Cash FlowLast quarter
$31.8M
$4.9M
Free Cash FlowOCF − Capex
$30.1M
FCF MarginFCF / Revenue
116.2%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
4.64×
0.44×
TTM Free Cash FlowTrailing 4 quarters
$51.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
BLFS
BLFS
Q4 25
$31.8M
$4.9M
Q3 25
$7.3M
$6.1M
Q2 25
$6.4M
$7.4M
Q1 25
$9.3M
$1.7M
Q4 24
$30.4M
$1.6M
Q3 24
$9.6M
$4.8M
Q2 24
$7.7M
$6.5M
Q1 24
$5.1M
$-4.5M
Free Cash Flow
BCML
BCML
BLFS
BLFS
Q4 25
$30.1M
Q3 25
$6.2M
Q2 25
$5.6M
Q1 25
$9.1M
Q4 24
$28.7M
Q3 24
$9.4M
Q2 24
$7.4M
Q1 24
$3.9M
FCF Margin
BCML
BCML
BLFS
BLFS
Q4 25
116.2%
Q3 25
24.3%
Q2 25
22.8%
Q1 25
37.6%
Q4 24
121.1%
Q3 24
36.6%
Q2 24
31.2%
Q1 24
16.1%
Capex Intensity
BCML
BCML
BLFS
BLFS
Q4 25
6.7%
Q3 25
4.3%
Q2 25
3.0%
Q1 25
0.6%
Q4 24
7.2%
Q3 24
1.0%
Q2 24
1.0%
Q1 24
4.7%
Cash Conversion
BCML
BCML
BLFS
BLFS
Q4 25
4.64×
0.44×
Q3 25
1.47×
9.83×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
0.13×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons